Previous 10 | Next 10 |
Baudax Bio (NASDAQ:BXRX) has regained compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2). Nasdaq staff made this determination of compliance after the company's bid price closed above $1.00/share for ten consecutive business days from Feb. 16, 2022 to Mar. 2,...
MALVERN, Pa., March 07, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, announced that the Company received a letter on March 3, 2022 from The Nasdaq Stock Market noting ...
Baudax Bio (NASDAQ:BXRX) has added ~3% in the pre-market Wednesday after the commercial-stage pharmaceutical company announced that the U.S. regulators issued a new patent related to its pain medication, Anjeso. The United States Patent No.11,253,478 covers the composition and the m...
MALVERN, Pa., March 02, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced that it has secured the issuance of United States Patent No.11,253,478 (the ȁ...
Recorded February 23, 2022. Noble Capital Markets Senior Research Analyst Gregory Aurand sits down with Baudax Bio President & CEO Gerri Henwood for this exclusive interview. Topics covered include: An overview of Baudax Bio and their product profile How are Anjeso commercial activities pr...
Announced offering. Last Friday, Baudax Bio announced a $10 million public offering, composed of 3,508,772 shares of common stock sold together with 3,508,772 warrants allowing for the purchase of a common share at $3.25. The offering price of the stock and warrant unit is $2.85. The warrants ...
Gainers: Inspirato (NASDAQ:ISPO) +48%. KAR Auction Services (NYSE:KAR) +40%. Farfetch (NYSE:FTCH) +39%. CarGurus (NASDAQ:CARG) +36%. Aerie (NASDAQ:AERI) +28%. IronNet (NYSE:IRNT) +26%. Nymox (NASDAQ:NYMX) +26%. Block (NYSE:SQ) +24%. Schrodinger (NASDAQ:SDGR) +21%. Paramount Group (NYSE:PGRE) ...
Gainers: Aerie Pharmaceuticals (NASDAQ:AERI) +25%. Schrodinger (NASDAQ:SDGR) +17%. MDxHealth (NASDAQ:MDXH) +16%. Lantheus (NASDAQ:LNTH) +13%. Tabula Rasa HealthCare (NASDAQ:TRHC) +13%. Losers: Baudax Bio BXRX -55%. The Joint (NASDAQ:JYNT) -15%. Biohaven...
Baudax Bio (NASDAQ:BXRX) is down 33.8% after hours after the firm has priced its previously announced underwritten public offering of 3,508,772 shares of common stock, together with warrants to purchase up to an aggregate of 3,508,772 shares of common stock for expected gross procee...
MALVERN, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, announced the pricing of its previousl...
News, Short Squeeze, Breakout and More Instantly...
Baudax Bio Inc. Company Name:
BXRX Stock Symbol:
NYSE Market:
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...
Baudax Bio Inc. (BXRX) is expected to report $-0.53 for Q3 2023